Full-Life Technologies
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
$150MSeries D+Debt
Role not disclosedActivity from announced rounds
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing